Suggested for -nE:
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type I (MPS I, decreased alpha-L-iduronidase activity) where quantitation of the glycosaminoglycans dermatan and heparan sulfate is desired...
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type II (MPS II, decreased iduronate-2-sulfatase) where quantitation of the glycosaminoglycans dermatan and heparan sulfate is desired in...
Second-tier testing of newborns with an abnormal primary screening result for mucopolysaccharidosis type II (MPS II, decreased iduronate-2-sulfatase) Follow-up testing for evaluation of an abnormal newborn screening result for MPS II This...
SCGCT - Overview: Neisseria gonorrhoeae, Self-Collect, Nucleic Acid Amplification, Throat
Detecting Neisseria gonorrhoeae using throat swabs collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications.
SCGCV - Overview: Neisseria gonorrhoeae, Self-Collect, Amplified RNA, Vaginal
Detecting Neisseria gonorrhoeae using vaginal swabs collected by the patient in a healthcare setting This test is not intended for use in medico-legal applications.
WAGDR - Overview: Alpha Globin Cluster Locus Deletion/Duplication, Blood
Diagnosis of alpha-thalassemia Carrier screening for individuals from high-risk populations for alpha-thalassemia This test is not useful for diagnosis or confirmation of beta-thalassemia or hemoglobinopathies.
MITAN - Overview: Mitotane, Plasma
Assessing compliance or making dosage adjustments for mitotane
MSMN - Overview: Membranous Nephropathy Target Antigen Identification, Mass Spectrometry, Tissue
Identification of antigen in membranous nephropathy
CRUZI - Overview: Trypanosoma cruzi (Chagas) Antibody Panel, Serum
Diagnosis of chronic Trypanosoma cruzi infection (Chagas disease) using two different methods
NHEP - Overview: Hereditary Erythrocytosis Gene Panel, Next-Generation Sequencing, Varies
Evaluating an individual with JAK2-V617F negative erythrocytosis associated with lifelong sustained increased red blood cell (RBC) mass, elevated RBC count, hemoglobin, or hematocrit Providing an extensive genetic evaluation for patients...